Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Jacob Smith

Jacob worked in the digital news team at Cancer Research UK from 2022 to 2024, writing for the news site and contributing to our podcast, That Cancer Conversation. He studied biochemistry at the University of Exeter and subsequently completed a Master’s in science communication at Imperial College London. He now works for the scientific journal Nature.
Showing 12 out of 70 results
An illustration of a T cell

With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals. With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals.

by Jacob Smith | Analysis | 31 October 2024

31 October 2024

A stack of cigarettes, one of them smoking

The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis shows The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis shows

by Jacob Smith | News | 9 July 2024

9 July 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Someone taking a cigarette out of a packet

A decade-long decline in the number of cigarettes a person who smokes has per day is at risk, a new Cancer Research UK study has revealed. A decade-long decline in the number of cigarettes a person who smokes has per day is at risk, a new Cancer Research UK study has revealed.

by Jacob Smith | News | 2 May 2024

2 May 2024

An abstract illustration of a DNA molecule

Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries

by Jacob Smith | In depth | 1 May 2024

1 May 2024

A medical professional holding a tube containing a blood sample

Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary. Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary.

by Jacob Smith | In depth | 23 April 2024

23 April 2024

A set of Flame of Hope 2024 awards

In March, we celebrated some of our outstanding volunteers at our 21st Flame of Hope Awards. Read the stories of 3 of our inspiring winners. In March, we celebrated some of our outstanding volunteers at our 21st Flame of Hope Awards. Read the stories of 3 of our inspiring winners.

by Jacob Smith | Personal stories | 11 April 2024

11 April 2024

A male patient with a female doctor during an appointment

Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed

by Jacob Smith | News | 14 March 2024

14 March 2024

Endometrial adenocarcinoma cells viewed under the microscope

Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer

by Jacob Smith | News | 8 March 2024

8 March 2024

Several types of non-cigarette tobacco, including cigars, cigarillos and a pipe

There are around five times more people smoking non-cigarette tobacco in England now than there were a decade ago, according to a new study There are around five times more people smoking non-cigarette tobacco in England now than there were a decade ago, according to a new study

by Jacob Smith | News | 5 March 2024

5 March 2024